Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Print this page Email this page Users Online: 280
Year : 2022  |  Volume : 11  |  Issue : 4  |  Page : 369-372

Hand foot skin reaction with multikinase inhibitor sorafenib - A rare case report

1 Professor and HOD of DVL, Viswabharathi Medical College, Penchikalapadu, Kurnool (Dt), Andhra Pradesh, India
2 2nd Year Post Graduate, Viswabharathi Medical College, Penchikalapadu, Kurnool (Dt), Andhra Pradesh, India

Correspondence Address:
Dr. S Gulabi
Department of DVL, Viswabharathi Medical College, Penchikalapadu, Kurnool (Dt) - 518 467, Andhra Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jdrntruhs.jdrntruhs_109_21

Rights and Permissions

Various metastatic solid tumors including renal cell carcinoma are treated with multikinase inhibitors like sorafenib and sunitinib which produce various cutaneous side effects. We report a case of sorafenib induced hand foot skin reaction, in a 75 year old female presented with complaints of bullae over palms and soles preceded by pain and burning sensation after first cycle of sorafenib chemotherapy 400mg BD for metastatic renal cell carcinoma. On examination, multiple tense, well defined tender bullae with surrounding erythema and with yellowish tinge on both palms and soles. She was advised for dose reduction of sorafenib to 200mg BD, topical clobetesol propionate and to avoid friction. She completed five cycles of sorafenib with said dose and was doing well. HFSR is a dose limiting cutaneous toxicity occurs within 3-6 weeks of treatment, dose reduction and simple treatment are sufficient to overcome. As the drug is excreted in the sweat glands it results in dose dependant direct skin toxicity .The differential diagnosis were hand foot syndrome, erythema multiforme, chemotherapy induced raynaud's disease, erythromelalgia, other cutaneous drug reactions. Awareness about the adverse cutaneous reaction to sorafenib is important to alert the clinicians which can be tackled successfully.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal